Stimulation of osteogenesis and angiogenesis of hBMSCs by delivering Si ions and functional drug from mesoporous silica nanospheres. (15th July 2015)

• Record Type: Journal Article
• Authors: Shi, Mengchao; Zhou, Yinghong; Shao, Jin; Chen, Zetao; Song, Botao; Chang, Jiang; Wu, Chengtie; Xiao, Yin
• Is Part Of: Acta biomaterialia. Volume 21(2015)
• Page Start: 178
• Page End: 189
• Publication Date: 2015-07-15
• Subjects: Mesoporous silica nanospheres -- Osteogenesis -- Angiogenesis -- Multifunction -- Bone regeneration; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1016/j.actbio.2015.04.019
• Languages: English
• ISSNs: 1742-7061

Abstract

Graphical abstract: Stimulation of osteogenesis and angiogenesis of human bone marrow stromal cells by mesoporous silica nanospheres and drug (DMOG) delivery. Abstract: Multifunctional bioactive materials with the ability to stimulate osteogenesis and angiogenesis of stem cells play an important role in the regeneration of bone defects. However, how to develop such biomaterials remains a significant challenge. In this study, we prepared mesoporous silica nanospheres (MSNs) with uniform sphere size (∼90 nm) and mesopores (∼2.7 nm), which could release silicon ions (Si) to stimulate the osteogenic differentiation of human bone marrow stromal cells (hBMSCs) via activating their ALP activity, bone-related gene and protein (OCN, RUNX2 and OPN) expression. Hypoxia-inducing therapeutic drug, dimethyloxaloylglycine (DMOG), was effectively loaded in the mesopores of MSNs (D-MSNs). The sustained release of DMOG from D-MSNs could stabilize HIF-1α and further stimulated the angiogenic differentiation of hBMSCs as indicated by the enhanced VEGF secretion and protein expression. Our study revealed that D-MSNs could combine the stimulatory effect on both osteogenic and angiogenic activity of hBMSCs. The potential mechanism of D-MSN-stimulated osteogenesis and angiogenesis was further elucidated by the supplementation of cell culture medium with pure Si ions and DMOG. Considering the easy handling characteristics of nanospheres, the prepared D-MSNs may be applied in the forms of injectable spheres for minimally invasive surgery, or MSNs/polymer composite scaffolds for bone defect repair. The concept of delivering both stimulatory ions and functional drugs may offer a new strategy to construct a multifunctional biomaterial system for bone tissue regeneration.